Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine
A majority of patients at a comprehensive cancer center who participated in clinical trial discussions through telemedicine reported a preference for telemedicine to complete the IC process. Telemedicine thus represents a valuable tool for reducing barriers to clinical trial participation, particularly in reducing travel and time barriers.
Authors
- Robert Michael Daly (ORCID: https://orcid.org/0000-0001-6573-7650)
- Katherine S. Panageas (ORCID: https://orcid.org/0000-0002-6591-604X)
- Michael J. Morris (ORCID: https://orcid.org/0000-0002-9454-0096)
- Allison Lipitz‐Snyderman (ORCID: https://orcid.org/0000-0003-2423-2220)
- Erin M. Bange (ORCID: https://orcid.org/0000-0003-0000-6093)
- Gilad J. Kuperman (ORCID: https://orcid.org/0000-0002-4130-1577)
- Peter D. Stetson (ORCID: https://orcid.org/0000-0002-8984-1302)
- Fernanda C. G. Polubriaginof (ORCID: https://orcid.org/0000-0003-2355-2556)
- Yasin Khadem Charvadeh (ORCID: https://orcid.org/0000-0002-2669-558X)
- Kenneth Seier (ORCID: https://orcid.org/0000-0003-3845-5249)
- Michael Buckley (ORCID: https://orcid.org/0000-0001-9150-1326)
- Sahil D. Doshi (ORCID: https://orcid.org/0000-0002-0261-4829)
- Deborah Schrag (ORCID: https://orcid.org/0000-0002-4334-5717)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Cornell University (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1200/op-24-00764
- Citations
- 1
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.88